FUJIFILM Postpones Announcement of Financial Results for the Fiscal Year 2020 due to COVID-19

Fujifilm just announced the postponement of the release of the financial results for the fiscal year ended March 31, 2020*. They need more time to make the report due to COVID-19.

They anticipate the inevitable: COVID-19 had a big impact on “some products“, and you can be sure cameras are one of those products.

The impact of COVID-19 is also seen on sales of some products and services. The effect on the performance for the fiscal year ended March 31, 2020 is currently under review and shall be notified as soon as we identified matters requiring disclosure

Overall, though, Fujifilm is in a better position than Nikon for example, as Fujifilm is a very diversified company. Down below you can see the yearly stock performance of Fujifilm, Nikon, Canon and Sony.

Also Nikon and other companies have postponed the fiscal year results announcement.

* the Japanese fiscal year 2020 started on the 1st of April 2019 and ended on the 31th of March 2020.

Our Owners Groups

Our Facebook Pages

Press Release

** CLICK HERE to Read the Rest of the Article **

Fujifilm Photography in Times of COVID-19 Quarantine, the FujiRumors Lockdown Diary and the Revival of the XF 55-200

I read somewhere, that about 4 billion people are forced to stay at home now to slow down and hopefully stop the spread of the COVID-19 Coronavirus.

In my country, the stunning Dolomites in Italy, we are locked in since over 1 month now. Of course I strictly follow the rules and never leave my apartment, except to buy food 1 or 2 times a week, and to quickly bring out my old dog in the fields just under my home.

Teaching Online

I continue to teach. Just online! With live streaming lessons, videos I upload on youtube [does this qualify me as a vlogger now??? ;) ], material I send to students via email and more. I try to do my best.

But the more I do it, the more I miss it to enter a classroom, write on a blackboard, smell the chalk, but most importantly, interact with my students.

But hey, these days there are people, who live far bigger challenges than me. So no complaint here. Just a wish that everything goes back to normal soon.

Lockdown Photography

The first weeks all went into figuring out how to do this online teaching. Trying different platforms for online live lessons, adapt my material to make it online teaching fit, figure out how to reach the various students best (some have only a smartphone, no computer, no printer, etc), and more practical issues to sort out.

But now that I have some sort of workflow, I can start thinking at my lockdown photography.

In my small rented apartment, I am running out of subjects rather quickly.

What I did now, is I started to take out my Fujinon XF55-200 lens, a lens I hardly use anymore since I own the Fujinon XF18-135mm (which never stops to surprise me, as you can see here).

The goal?

Get a decent shot of the little birds flying around my balcony, and the XF55-200 is the best lens in my arsenal for that. So it gets its revival now!

So far I have failed, though, not for the limits of the gear, but because of my lack of skills. But I have time to practice, improve, and I will upload an image on my instagram if I get a decent shot.

Inspiration

Another thing I like to do, is to check out all our facebook groups, and see how other fellow Fujifilm X and GFX shooters deal with these lockdown days and what they shoot.

I have picked out some images and shared them below. May them motivate you (and me) to stand up, and do the best out of this situation, also photographically speaking.

COVID-19 Image Roundup

** CLICK HERE to Read the Rest of the Article **

FUJIFILM Announces Start in USA of Clinical Phase II Trial of Antiviral Drug AVIGAN for COVID-19 Patients

Fujifilm has just issued a press release, where they officially announce that their anti-influenza virus drugs “Avigan ® Tablets” has started a clinical phase II study in patients new coronavirus infection in the United States.

The purpose of this study is to confirm the therapeutic efficacy and safety of Avigan.

The study is scheduled to be conducted at three facilities: Brigham and Women’s Hospital, Massachusetts General Hospital, and Massachusetts State University Medical School.

In case you are unaware of the different phases, down below is a table taken from wikipedia.

In Japan, they are at Phase III of the tests already, as we reported here.

Press Release

** CLICK HERE to Read the Rest of the Article **

Fujifilm Drug Avigan (Favipiravir) For COVID-19 (Coronavirus) Treatment Tested Worldwide (USA included) and Offered for Free to 20 Countries

Last month we reported how Zhang Xinmin, director of the science ministry’s China National Center for Biotechnology Development, said that the Fujifilm produced drug Avigan “has a high degree of safety and is clearly effective in treatment” and how a Japanese health ministry source suggested the drug was not as effective in people with more severe symptom.

A few days later, Fujifilm published another official statement, where they announce the start of phase III clinical trial of “Avigan” on COVID-19 Coronavirus and the commitment to increase production.

Avigan is currently tested all over the world, including here in Italy, where I live. But also in USA and many other countries.

Moreover, Japan plans to provide the anti-flu drug Avigan for free to 20 countries hoping to use it to treat coronavirus patients, Foreign Minister Toshimitsu Motegi said Tuesday.

As a consequence, Fujifilm ramped up production of flu drug Avigan as possible COVID-19 treatment.

Fujifilm or not, let’s hope some cure comes up soon, or this unreal situation will keep up for a long time.

Our Owners Groups

Our Facebook Pages

via japantimes via fiercepharma via nypost